Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.

By Esther Buytaert, M. Dewaele, P. Agostinis. Biochimica et Biophysica Acta, 2007

723 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Pulmonary and Respiratory Medicine, Toxicology

View Paper: https://www.semanticscholar.org/paper/3d95b78da811c3f4f59d2749216383a37161441d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

In Pulmonary and Respiratory Medicine

Citations in the corpus

Reactive Oxygen Species Signaling and Oxidative Stress: Transcriptional Regulation and Evolution (2024, background): “Therefore, moving forward, further studies should delve into broader comparative genomics and functional studies across a wider array of species, to unravel the diverse nuances and evolutionary trajectories of ROS-related mechanisms.”
Lysosomal membrane permeabilization in cell death (2008, background): “Photodynamic therapy combines a drug (a photosensitizing agent) with a specific wavelength of light to induce the generation of ROS that kill cancer cells (Buytaert et al., 2007).”
Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. (2009, background): “Lastly, the acute inflammation and release of cytokines and stress response proteins induced in the tumor by PDT can lead to an invasion of leukocytes that can both contribute to tumor destruction as well as stimulate the immune system to recognize and destroy tumor cells even at isolated locations ”
Cell Death Pathways in Photodynamic Therapy of Cancer (2011, background): “The crucial factors in determining the type of cell death, e.g., apoptosis or necrosis following PDT are: the cell type, the presence of an intact set of apoptosis machinery, the subcellular localization of the PS, the light dose applied to activate it locally, and the oxygen partial pressure [103].”
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions (2017, background): “However, numerous other apoptotic signal transduction pathways that are being activated upon photodamage have been described (reviewed extensively by [24,27,28]).”
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death (2012, neutral): “This difference between Hyp-PDT and PF-PDT in ecto-CRT induction might be due to the more pronounced ER localization of hypericin when compared with photofrin (Buytaert et al , 2007; Szokalska et al , 2009; Luo et al , 2010).”
Fluorescent proteins and their applications in imaging living cells and tissues. (2010, background): “There are two main types of photosensitizer reactions involving either electron or energy transfer as a primary process (54, 226).”
Photodynamic therapy of cancer. Basic principles and applications (2008, background): “In this case, the primary localisation site could not be decisive for cell death but an effective photodamage would take place in the secondary sites where the PS is re-localised [27, 28].”
PHOTODYNAMIC THERAPY OF CANCER: AN UPDATE (2011, background): “can be a permissive signal for MOMP and the subsequent release of caspase activators such as cytochrome c and Smac/DIABLO, or other proapoptotic molecules, including apoptosis-inducing factor (AIF).(26) Lysosomal membrane rupture and leakage of cathepsins from photo-oxidized lysosomes(30,31) induces”